Lennox-Gastaut Syndrome: Improving Patient Outcomes through Better Diagnosis and Management
Speakers: Georgia D. Montouris, MD, Associate Clinical Professor of Neurology
Juliann Paolicchi, MD, Clinical Professor, Pediatrics, Neurology
Duration: 60 minutes
Presented on: October 7, 2016
Georgia D. Montouris, MD
Georgia D. Montouris, MD
Associate Clinical Professor of NeurologyGeorgia Montouris, MD, is Director of Epilepsy Services and Clinical Associate Professor of Neurology, Boston University School of Medicine. She studied at the Universite Libre de Bruxelles, Brussels, Belgium and did her residency at Vanderbilt University School of Medicine, Nashville TN. She was in private practice in Nashville specializing in epilepsy in adults and children, then moved on as medical director at Epi-Care, a comprehensive epilepsy center in Memphis, TN. From 1999 -2002, she worked at the Comprehensive Epilepsy Center for Children and Adults in St. Louis, before coming to Boston Medical Center, where she began the comprehensive epilepsy center at Boston Medical Center, in 2002 which is listed as a Level 4 epilepsy monitoring center.
Juliann Paolicchi, MD
Juliann Paolicchi, MD
Clinical Professor, Pediatrics, NeurologyJuliann Paolicchi, MD, is the director of Pediatric Epilepsy for New York, the co-director of Pediatric Epilepsy Research at Northeastern Regional Epilepsy Group, and a clinical professor at Rutgers Medical Center. She earned her MD at Johns Hopkins University, and completed her residency in pediatrics at Children's Hospital of Philadelphia, Pennsylvania. Dr Paolicchi has conducted research on the genetics of epilepsy and continues to pursue collaborative outcome-based research for the treatment of children with epilepsy. She has participated in a wide variety of multi-institute clinical research trials, has numerous publications in her field, and is a renowned educator and national speaker in the treatment of epilepsy and the genetic influences on brain development.
Lennox-Gastaut Syndrome: Improving Patient Outcomes Through Better Diagnosis and Management
Presented by the Albert Einstein College of Medicine and Montefiore Medical Center in Joint Providership with PlatformQ Health Education, LLC.
ACKNOWLEDGEMENT This educational activity is supported by an educational grant from Lundbeck.
ACCREDITATION STATEMENT The activity has been planned and implemented in accordance with requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS Live Internet Activity Albert Einstein College of Medicine designates this live internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Enduring Material Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hour of Category 1 credit for completing this program
DATE OF RELEASE/EXPIRATION Live Activity Friday, October 7, 2016 from 10:00AM EST – 11:00AM EST Enduring Material The enduring material will be available from Friday, October 7, 2016 to Saturday, October 13, 2017.
LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:
• Identify characteristics associated with LGS from other forms of epilepsy, and evolving seizure profiles over the course of a patient's life • Devise effective and tolerable pharmacotherapeutic treatment options for LGS as appropriate to pediatric and adult patients • Evaluate the relative efficacy and safety of alternative therapies and nonpharmacologic strategies for the management of LGS • Describe the key elements of a care ploan that will ensure snooth transition from periatric care to adult care in patients with LGS
TARGET AUDIENCE US-based epileptologists, community neurologists (pediatric and adult), primary care physicians, pediatricians, medical directors from long-term care facilities, and other clinicians involved in the care of patients with Lennox-Gastaut Syndrome.
ESTIMATED TIME TO COMPLETE This activity consists of one session, which should take approximately 1 hour to complete.
METHOD OF PARTICIPATION There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
DISCLOSURE OF CONFLICTS OF INTEREST The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Presenters Disclosures Georgia D. Montouris, MD Consultant, Scientific Advisory Board: Eisai, Acorda, Lundbeck, Upsher-Smith, Sunovion Expert Panel for Pregnancy Registry: UCB Juliann Paolicchi, MD
Speaker's Bureau: Lundbeck, LivaNova Contracted Research: Zogenix
Providers Disclosures Einstein–Montefiore Center for Continuing Medical Education The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity. Peer Reviewer Disclosures Solomon L. Moshe, MD Decision Resources Group – DRG; PharmaQ Health, Inc.; LEK Consulting LLC; Health Advances, LLC; Gerson Lehman Group Name of Planner Reported Financial Relationship Anne Roc, Medical Director Has nothing to disclose relevant to this activity. Randi O'Hara, Senior Program Manager Has nothing to disclose relevant to this activity.
CONTACT INFORMATION Accreditation Support: Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to email@example.com.
Technical Support: For issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.